Placental mesenchymal dysplasia, a case of intrauterine sudden death of fetus with rupture of cirsoid periumbilical chorionic vessels
- Takeshi Umazume†1,
- Soromon Kataoka†1Email author,
- Kyouko Kamamuta†1,
- Fumie Tanuma†1,
- Akihiko Sumie†1,
- Toru Shirogane†1,
- Takayuki Kudou†1 and
- Hitoshi Ikeda†2
© Umazume et al; licensee BioMed Central Ltd. 2011
Received: 25 January 2011
Accepted: 24 April 2011
Published: 24 April 2011
We report a 32-year-old woman (1-gravid, 1-para) with a vesicular lesion in her uterus that was pointed out on ultrasound at 8 weeks' gestation. Amniocentesis at 15 weeks' gestation showed a normal female karyotype, 46XX. As the pregnancy advanced, the mole-like lesion became relatively reduced. Throughout gestation, the maternal human chorionic gonadotropin level was normal, but the serum alpha fetoprotein level rose as her pregnancy progressed. Her fetus did not exhibit any remarkable anomalies. The patient visited our hospital complaining of a diminished feeling of fetal movements at 36 weeks 5 days' gestation, and intrauterine fetal death (IUFD) was confirmed. She delivered a 2336-g female without any definite anomalies. A pathological examination led to a diagnosis of placental mesenchymal dysplasia, and androgenetic/biparental mosaicism in the placenta was identified using p57kip2 immunohistochemical staining. And it also revealed that the rupture of the cirsoid chorionic vessels had led to IUFD.
The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1030203924510721.
Placental mesenchymal dysplasia (PMD) is a rare placental anomaly characterized by placentomegaly and grapelike vesicles resembling molar pregnancy. The incidence of PMD is reportedly 0.02% , with a definite preponderance of females . Distinguishing PMD from its mimics, especially molar pregnancy is important for preventing the unnecessary termination of pregnancy. Unlike molar pregnancies, PMD usually features a normal fetus. However, PMD is distinct in that it has a high incidence of fetal growth restriction (FGR) and intrauterine fetal death (IUFD), and is associated with Beckwith-Wiedemann syndrome (BWS), a condition characterized by macrosomia, visceromegaly, macroglossia, and omphalocele . Pathologically, PMD placentas are usually large size, and show edema of stem villi with intact terminal villi and many kinds of vascular anomalies, such as cirsoid chorionic vessels, thrombosis, thickness of vessel wall, vascular stenosis, villous chorangiosis, chorioangioma and fetal thrombotic vasculopathy. Also abnormal umbilical cords, including tortuous, marked twisted cords, excessively long cords, etc. [2, 3]. These vascular anomalies may lead to FGR and IUFD. Absence of trophoblastic proliferation in PMD placentas is a histological difference from partial moles . Although the pathogenesis of PMD remains unknown, androgenetic/biparental mosaicism has recently been suggested as the underlying cause of PMD . The phenotypic features of PMD, including the absence of trophoblastic hyperplasia, its association with BWS, and its female preponderance, can all be explained by this novel mechanism. We report a new case of PMD without BWS, but intrauterine sudden death of the fetus without any anomaly contained FGR, at 36 weeks' gestation.
The main differential diagnoses of PMD are partial hydatidiform mole, dichorionic twins of a normal fetus and complete mole, and confined placental mosaicism. When a prenatal ultrasonographic examination detects a vesicular lesion in the presence of a fetus in uterus, whether a single or twin pregnancy is present should be determined. A twin pregnancy would consist of dichorionic twins of a normal fetus and complete mole. In the present case, ultrasound appeared to reveal a single pregnancy. Unlike partial moles, the majority of PMD are diploid . In 70 - 80% of cases, the partial moles are triploid, often with 2 sets of paternal genes and 1 set of maternal genes as a result of dispermy fertilization . Cases of confined placental mosaicism involving trisomy 16 have been reported as exhibiting cystic villi on ultrasound, but these cases can be diagnosed accurately by karyotyping . In the present case, an amniocentesis performed at 15 weeks' gestation showed a normal female karyotype, 46XX. The characteristic laboratory test for PMD includes an increased level of maternal serum AFP. The increase in the surface transfer area as a result of the increased placental volume and the increased number of vessels within the stem villi is thought to lead to an increased transfer of AFP into the maternal circulation . On the other hand, unlike with moles, the level of hCG in patients with PMD is normal to slightly increased throughout gestation . In this case, although the maternal hCG level was normal throughout gestation, the serum AFP level increased as her pregnancy progressed. These prenatal findings suggested a diagnosis of PMD.
The placenta is usually extremely large for the gestational age and the umbilical cord is relatively long in cases with PMD [2, 3]. The gross placental findings for PMD vary with gestational age. To our knowledge, no previous report has detected a vesicular lesion in a patient with PMD prior to 13 weeks' gestation. In the present case, a vesicular lesion was detected at 8 weeks' gestation. Thus, the morphological changes in the villi appear to begin early during gestation. During the third trimester, the chorionic plate vessels in a PMD placenta are aneurysmally dilated and tortuous . However, in cases terminated before 20 weeks of gestation, the chorionic plate vessels are not dilated, and the normal and abnormal areas are not clearly delineated, suggesting that the vascular malformations develop progressively . As the pregnancy advances, tangled congested vessels grossly resembling gray-white or dark-red wormlike structures may be identified within the parenchyma and are often most prominent in the subchorionic plate region near the fetal surface . An ultrasound performed at 33 weeks' gestation seemingly detected this finding (Figure 2).
Although morphologic gross findings of PMD placentas are so often mimicked by features of partial hydatidiform moles, PMD placentas are markedly enlarged and macroscopic vascular anomalies such as cirsoid dilated chorionic vessels with or without thrombi and umbilical cord anomalies like a long umbilical cord that were observed in our case are often co-existence in PMD placentas, but they are not usual in molar pregnancies [2, 13]. Microscopically, PMD placentas typically reveal large stem villi with hydropic swelling and cistern formation interspersed with unaffected terminal villi. Similarly, mixture of hydropic villi with cistern formation and unaffected villi are also found in partial hydatidiform moles, however, trophoblastic stromal inclusions and proliferations, which are absent in PMD placentas, are also characteristic of molar pregnancies. Not only macroscopic but also microscopic vascular anomalies such as fetal thrombotic vasculopathy that was found in our case, villous chorangiosis and chorangioma, are also characteristic together hydropic villi in PMD placentas, but not in molar pregnancies [2, 3, 13]. These morphological characteristics of PMD placenta supported to diagnose our case as PMD. Immunohistochemistry using antibodies against products of paternal imprinting genes such as the antibody against p57kip2 protein is a potential marker that may prove helpful in distinguishing PMD from molar pregnancy. The immunohistochemical detection of androgenetic/biparental mosaicism in stromal cells suggests to a diagnosis of PMD, because this mosaicism is unusual in molar pregnancies . Dichorionic twin placentas with a normal fetus and complete mole may also be needed to pathologically distinguish to PMD. But, vascular anomalies seen in PMD placentas are absent in their placentas and complete moles are purely androgenetic. Spontaneous abortion with hydropic change may have vesicle formation and can also be confused with early PMD, however, the vesicles, if present, are usually small. Also, spontaneous abortion shows degenerative changes .
PMD has distinct clinicopathological features. According to Truc et al. , 82% of the affected fetuses are female and about 20% of cases with PMD also have BWS. Among the PMD cases without BWS, the FGR and the IUFD rate are 50% and 36%, respectively. IUFD can occur throughout gestation (before 21 weeks, 14.3%; 22~27 weeks, 23.8%; 28~33 weeks, 33.3%; after 34 weeks, 28.6%). The cause of IUFD is currently unclear and may be heterogeneous. Thrombosis of chorionic vessels and umbilical cord anomalies are thought to be likely causes of IUFD in PMD cases, and Truc et al. reported that IUFD may be explained by a potentially chronic hypoxia secondary to obstructive fetal vascular thrombosis and a decrease in maternal-fetal gas exchange as a result of an insufficient amount of normal chorionic villi and the shunting of blood from the exchange surface in chorioangiomas and dysplastic villi . In our case, histological examination revealed that the dilated cirsoid chorionic vessels were fragile and that part of the vessel wall had ruptured, resulting in hemorrhage with hematoma formation. Although fetal thrombotic vasculopathy was found in a part of the affected lesion, this hemorrhage was thought to have led to sudden death of the fetus at the late gestational age (36 weeks 5 days) because no significant chronic hypoxic anomaly of the fetus including FGR was observed.
The underlying cause of PMD is currently unknown. Recently, Kaiser-Rogers et al. proposed androgenetic/biparental mosaicism as the origin of some cases of PMD and suggested that the phenotype of androgenetic mosaicism can presumably range from mild PMD, which may not even be diagnosed, to the typical findings of a complete hydatidiform mole, depending on the extent and distribution of the androgenetic lineage . The authors hypothesized that such mosaicism arose as the result of a failure in the replication of the maternal genome prior to the first cleavage, with normal replication and segregation of the paternal genome, resulting in two types of daughter cells, one with normal biparental genes and the other with only paternal genes. Such failed division would produce a diploid/haploid mosaic embryo, and endoreduplication of the haploid paternal-only daughter cell could then occur to produce the diploid androgenetic lineage, while the female and male haploid complements would merge to form a daughter cell with normal biparental inheritance. The phenotypic features of PMD, including the preponderance of females, the absence of trophoblastic hyperplasia, and the association with BWS, can all be explained by this mechanism. Since an androgenic 46, YY cell line would be nonviable, PMD cases would show the marked female predominance. The abnormal androgenetic cells would be confined to the chorionic mesoderm, membranes, and vessels, whereas the trophoblastic cells would be normal with no evidence of androgenetic cells . This feature would explain the absence of trophoblast overgrowth in PMD in contrast to complete moles, in which androgenetic cells are identified in the trophoblastic cell layer. BWS is a condition of constitutional overgrowth with genetic linkage to chromosome 11p15.5. . Insulin-like growth factor-2 is located in this lesion, and the maternal allele is normally suppressed so that only the paternal gene is expressed. Thus, the loss of 11p15.5. gene imprinting could lead to PMD in some cases.
PMD should be included in a differential diagnosis of cystic lesions of the placenta by sonography, especially when a phenotypically normal-appearing fetus can be identified. When the prenatal characteristics of PMD, such as an elevated AFP and normal hCG level in the mother, a normal female karyotype revealed by amniocentesis, and dilated subchorionic vessels revealed by ultrasonography during the third trimester, are detected, termination of the pregnancy at an optimal time could be considered, since sudden IUFD including rupture of the cirsoid chorionic vessels might occur at any time throughout gestation.
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in Chief of this Journal.
We thank Dr. Kanako Kubota, Department of Surgical Pathology, Hokkaido University Hospital, for performing the immunohistochemical staining of p57kip2.
- Arisawa M, Nakayama M: Suspected involvement of the X chromosome in Placental mesenchymal dysplasia. Cong Anomal. 2002, 42: 309-317. 10.1111/j.1741-4520.2002.tb00897.x.View ArticleGoogle Scholar
- Truc P, Julie S, Carla S: Placental Mesenchymal Dysplasia is associated with high rates of intrauterine growth restriction and fetal demise. A report of 11 new cases and a review of the literature. Am J Clin Pathol. 2006, 126: 67-78. 10.1309/RV45HRD53YQ2YFTP.View ArticleGoogle Scholar
- Parveen Z, Tongson-Ignacio JE, Fraser CR, Killeen JL, Thompson KS: Placental mesenchymal dysplasia. Arch Pathol Lab Med. 2007, 131: 131-137.PubMedGoogle Scholar
- Moscoso G, Jauniaux E, Hustin J: Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia. A new clinico-pathological entity?. Pathol Res Pract. 1991, 187: 324-328. 10.1016/S0344-0338(11)80791-0.View ArticlePubMedGoogle Scholar
- Kaiser-Rogers KA, McFadden DE, Livasy CA, Dansereau J, Jiang R, Knops JF, Lefebvre L, Rao KW, Robinson WP: Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet. 2006, 43: 187-192.PubMed CentralView ArticlePubMedGoogle Scholar
- Natori M, Tanaka M, Ishimoto H, Gohda N, Kiyokawa K, Yamauchi J, Miyazaki T, Kobayashi T, Nozawa S, Takagi T: Relation of gestational age, maternal body weight and age or serum alpha-fetoprotein and human chorionic gonadotropin at second-trimester. Nippon Sanka Fujinka Gakkai Zasshi. 1994, 46: 562-566.PubMedGoogle Scholar
- Matsuoka S, Thompson JS, Edwards MC, Bartletta JM, Grundy P, Kalikin LM, Harper JW, Elledge SJ, Feinberg AP: Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Natl Acad Sci USA. 1996, 93: 3026-3030. 10.1073/pnas.93.7.3026.PubMed CentralView ArticlePubMedGoogle Scholar
- Lokan J, Chan YF, Agnesta F: Placental mesenchymal dysplasia. Pathology. 2002, 34: 375-378. 10.1080/003130202760120571.View ArticlePubMedGoogle Scholar
- Jauniaux E, Kadri R, Hustin J: Partial mole and triploidy: screening patients with first-trimester spontaneous abortion. Obstet Gynecol. 1996, 88: 616-619. 10.1016/0029-7844(96)00235-9.View ArticlePubMedGoogle Scholar
- Astner A, Schwinger E, Caliebe A, Jonat W, Gembruch U: Sonographically detected fetal and placental abnormalities associated with trisomy 16 confined to the placenta. A case report and review of the literature. Prenat Diagn. 1998, 18: 1308-315. 10.1002/(SICI)1097-0223(199812)18:12<1308::AID-PD443>3.0.CO;2-H.View ArticlePubMedGoogle Scholar
- Paradinas FJ, Sebire NJ, Fisher RA, Rees HC, Foskett M, Seckl MJ, Newlands ES: Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology. 2001, 39: 447-454. 10.1046/j.1365-2559.2001.01256.x.View ArticlePubMedGoogle Scholar
- Jauniaux E, Nicolaides KH, Hustin J: Perinatal features associated with placental mesenchymal dysplasia. Placenta. 1997, 18: 701-706. 10.1016/S0143-4004(97)90012-6.View ArticlePubMedGoogle Scholar
- Benirschke K, Kaufmann P, Baergen RN: Molar Pregnancy: partial hydatidiform mole. Pathology of the Human Placenta. Edited by: Benirschke K, La Jolla, Kaufmann P, Aachen, Baergen RN. 2006, New York: Springer Science+Business Media, Inc, 817-825. 5Google Scholar
- Hoffner L, Dunn J, Esposito N, Macpherson T, Surti U: p57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum Pathol. 2008, 39: 63-72. 10.1016/j.humpath.2007.05.010.View ArticlePubMedGoogle Scholar
- Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP: Genetic linkage of Beckwith-Wiedemann syndrome to 11p15.5. Am J Hum Genet. 1989, 44: 720-723.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.